US Pharma MarketingQure.ai's chief medical officer Dr Javier J Zulueta discusses APAC's barriers to scaling AI-enabled lung cancer detection and what a workable model could look like. As the Asia-Pacific region confronts a growing lung cancer burden, particularly its relevance among those unlikely high-risk patients like never smokers, the assistance of AI has become more necessary and practical than ever in population-wide screening efforts. In lung screenings, AI has helped doctors catch warning signs that may otherwise be missed during emergency visits, pre-surgery checks, or general health screenings. But turning that promise into wider screening programmes is not straightforward. Many health systems…
As the Asia-Pacific region confronts a growing lung cancer burden, particularly its relevance among those unlikely high-risk patients like never smokers, the assistance of AI has become more necessary and practical than ever in population-wide screening efforts.
In lung screenings, AI has helped doctors catch warning signs that may otherwise be missed during emergency visits, pre-surgery checks, or general health screenings.
Source: MobiHealthNews